Last reviewed · How we verify
Fosamax
Fosamax is a Small molecule drug developed by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine. It is currently FDA-approved. Also known as: alendronate sodium, Alendronate sodiuum.
At a glance
| Generic name | Fosamax |
|---|---|
| Also known as | alendronate sodium, Alendronate sodiuum |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head (PHASE2)
- Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes (PHASE2)
- Prospective, Randomized, Multicenter Clinical Trial of Bisphosphonates Combined With Vancomycin for the Treatment of Cierny-Mader Type I and III Osteomyelitis (PHASE3)
- Alendronate for Osteonecrosis in Adults With Sickle Cell Disease (PHASE2)
- Bone, Exercise, Alendronate, and Caloric Restriction (PHASE4)
- Alendronate to Reduce Pelvic Insufficiency Fractures in Cervical Cancer Patients Undergoing Chemoradiation (PHASE1, PHASE2)
- Bone Turnover Markers and Treatment Efficacy in Postmenopausal Osteoporosis (NA)
- The Optimal Sequential Therapy After Long Term Denosumab Treatment (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Fosamax CI brief — competitive landscape report
- Fosamax updates RSS · CI watch RSS
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine portfolio CI
Frequently asked questions about Fosamax
What is Fosamax?
Fosamax is a Small molecule drug developed by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine.
Who makes Fosamax?
Fosamax is developed and marketed by Xinhua Hospital, Shanghai Jiao Tong University School of Medicine (see full Xinhua Hospital, Shanghai Jiao Tong University School of Medicine pipeline at /company/xinhua-hospital-shanghai-jiao-tong-university-school-of-medicine).
Is Fosamax also known as anything else?
Fosamax is also known as alendronate sodium, Alendronate sodiuum.
What development phase is Fosamax in?
Fosamax is FDA-approved (marketed).
Related
- Manufacturer: Xinhua Hospital, Shanghai Jiao Tong University School of Medicine — full pipeline
- Therapeutic area: All drugs in Other
- Also known as: alendronate sodium, Alendronate sodiuum
- Compare: Fosamax vs similar drugs
- Pricing: Fosamax cost, discount & access